Pharmacotherapeutics – Introduction, scope, and objectives. Rational use of Medicines, Evidence Based Medicine, Essential Medicines List, Standard Treatment Guidelines (STGs)

Definition, etiopathogenesis, clinical manifestations, nonpharmacological and pharmacological management of the diseases associated with (a) Cardiovascular System  Hypertension  Angina and Myocardial infarction  Hyperlipidaemia  Congestive Heart Failure (b) Respiratory System  Asthma  COPD (c) Endocrine System  Diabetes  Thyroid disorders - Hypo and Hyperthyroidism

Definition, etiopathogenesis, clinical manifestations, nonpharmacological and pharmacological management of the diseases associated with (d) Central Nervous System  Epilepsy  Parkinson’s disease  Alzheimer’s disease  Stroke  Migraine (e) Gastro Intestinal Disorders  Gastro oesophageal reflux disease  Peptic Ulcer Disease  Alcoholic liver disease  Inflammatory Bowel Diseases (Crohn’s Disease and Ulcerative Colitis) (f) Haematological disorders  Iron deficiency anaemia  Megaloblastic anaemia

Definition, etiopathogenesis, clinical manifestations, nonpharmacological and pharmacological management of the diseases associated with (g) Infectious diseases  Tuberculosis  Pneumonia  Urinary tract infections  Hepatitis  Gonorrhoea and Syphilis  Malaria  HIV and Opportunistic infections  Viral Infections (SARS, CoV2) (h) Musculoskeletal disorders  Rheumatoid arthritis  Osteoarthritis (i) Dermatology  Psoriasis  Scabies  Eczema (j) Psychiatric Disorders  Depression  Anxiety  Psychosis

Definition, etiopathogenesis, clinical manifestations, nonpharmacological and pharmacological management of the diseases associated with (k) Ophthalmology  Conjunctivitis (bacterial and viral)  Glaucoma (l) Anti-microbial Resistance 2 (m) Women’s Health  Polycystic Ovary Syndrome  Dysmenorrhea  Premenstrual Syndrome